Israel Englander Cyma Bay Therapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $6.6 Million - $12.8 Million	-522,664 Reduced 36.2%	921,330 $21.8 Million
Q2 2023 Aug 14, 2023	SELL	$7.47 - $10.95 $11.2 Million - $16.5 Million	-1,505,062 Reduced 51.04%	1,443,994 $15.8 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $11.9 Million - $19.4 Million	2,018,868 Added 217.04%	2,949,056 $25.7 Million
Q4 2022 Feb 14, 2023	SELL	$3.22 - $6.27 $1.94 Million - $3.79 Million	-603,794 Reduced 39.36%	930,188 $5.83 Million
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $4.1 Million - $6.3 Million	-1,481,514 Reduced 49.13%	1,533,982 $5.37 Million

Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $1.11 Million - $2.18 Million	642,796 Added 27.09%	3,015,496 $8.9 Million
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $836,299 - $1.1 Million	301,913 Added 14.58%	2,372,700 $7.38 Million
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $362,192 - $515,816	112,134 Added 5.73%	2,070,787 $7 Million
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $500,231 - $637,182	-144,159 Reduced 6.86%	1,958,653 $7.15 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $4.92 $193,190 - $241,242	49,033 Added 2.39%	2,102,812 $9.17 Million
Q1 2021 May 17, 2021	BUY	$4.23 - $6.55 $2.99 Million - $4.64 Million	707,731 Added 52.58%	2,053,779 $9.32 Million
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $1.93 Million - $3.04 Million	-336,355 Reduced 19.99%	1,346,048 $7.73 Million
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $2.78 Million - $6.07 Million	838,446 Added 99.35%	1,682,403 $12.2 Million
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $1.01 Million - $3.03 Million	-713,183 Reduced 45.8%	843,957 $2.95 Million
Q1 2020 May 14, 2020	SELL	$1.25 - $2.02 $1.8 Million - $2.9 Million	-1,436,505 Reduced 47.99%	1,557,140 $2.31 Million
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $971,102 - $4.33 Million	-730,152 Reduced 19.61%	2,993,645 $5.87 Million
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $3.79 Million - $5.34 Million	740,380 Added 24.82%	3,723,797 $19.1 Million
Q2 2019 Aug 15, 2019	BUY	$6.05 - $13.66 $13.6 Million - $30.6 Million	2,240,912 Added 301.8%	2,983,417 $21.4 Million
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $5.8 Million - $13.1 Million	-959,195 Reduced 56.37%	742,505 $16.7 Million
Q1 2019 May 14, 2019	BUY	$8.16 - $13.42 $4.39 Million - $7.23 Million	538,548 Added 46.3%	1,701,700 $22.6 Million
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $1.66 Million - $2.97 Million	253,377 Added 27.85%	1,163,152 $9.15 Million
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $2.82 Million - $3.76 Million	-258,857 Reduced 22.15%	909,775 $10.1 Million
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $89,085 - $120,173	8,357 Added 0.72%	1,168,632 $15.7 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $9.85 Million - $16.6 Million	1,094,594 Added 1666.53%	1,160,275 $15.1 Million
Q4 2017 Feb 14, 2018	SELL	$7.67 - $9.31 $12.6 Million - $15.2 Million	-1,637,443 Reduced 96.14%	65,681 $604,000
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $10.1 Million - $14.1 Million	1,703,124	1,703,124 $13.7 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account